Medline Inc. income statement MDLN

In Q3 of fiscal 2026, the quarter ended Sep 26, 2026, Medline Inc. reported revenue of $7.9 billion. Net income was $318.0 million, a profit margin of 4.0%. Operating income came to $500.0 million, an operating margin of 6.4%. Diluted earnings per share were $0.22.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 26, 2026
Q3 FY2026
Sep 26, 2026
Q2 FY2026
Jun 27, 2026
Q1 FY2026
Mar 28, 2026
Revenue
—
7,856
7,685
7,352
Cost of revenue
—
5,931
5,470
5,511
Gross profit
—
1,925
2,215
1,841
Selling, general and administrative
—
1,259
1,295
1,228
Other operating income (expense)
—
10
-348
-15
Operating income
—
500
395
422
Interest income
—
47
49
29
Interest expense
—
165
168
165
Foreign currency gain (loss)
—
5
1
4
Other non-operating income (expense)
—
-1
-42
1
Pretax income
—
386
235
291
Income tax
—
68
96
52
Net income
—
318
139
239
Net income to common
—
198
59
132
Basic EPS
—
0.23
0.07
0.16
Diluted EPS
—
0.22
0.07
0.16
Weighted average shares, basic
—
876
857
819
Weighted average shares, diluted
—
1,316
861
825
Other measures
Depreciation and amortization
—
259
256
254
EBITDA
—
759
651
676
Interest coverage
—
3.03x
2.35x
2.56x
Margins
Gross margin
—
24.50%
28.82%
25.04%
Operating margin
—
6.36%
5.14%
5.74%
Pretax margin
—
4.91%
3.06%
3.96%
Profit margin
—
4.05%
1.81%
3.25%
EBITDA margin
—
9.66%
8.47%
9.19%
Effective tax rate
—
17.62%
40.85%
17.87%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MDLN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Northfield, IL
SEC filer status
Non-accelerated filer
SEC CIK
2046386

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.